[Peripheral vasodilator agents in cardiology].
D002986:Clinical Trials as Topic; D003331:Coronary Vessels / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000188:drug therapy*; D009566:Nitrates / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D009566:Nitrates; D010879:Piperazines; D011799:Quinazolines; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; C005185:trimazosin; D005996:Nitroglycerin; D011224:Prazosin; D010646:Phentolamine
Perifericheskie vazodilatory v kardiologii.